Search

Fazli Erdem

Examiner (ID: 14311, Phone: (571)272-1914 , Office: P/2826 )

Most Active Art Unit
2826
Art Unit(s)
2826, 2812
Total Applications
1709
Issued Applications
1393
Pending Applications
122
Abandoned Applications
216

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18903008 [patent_doc_number] => 20240018493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/251941 [patent_app_country] => US [patent_app_date] => 2021-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30316 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -100 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251941 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/251941
KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION Nov 9, 2021 Pending
Array ( [id] => 20193838 [patent_doc_number] => 20250270548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING TARDBP ASSOCIATED DISEASES [patent_app_type] => utility [patent_app_number] => 18/039928 [patent_app_country] => US [patent_app_date] => 2021-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18132 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039928 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/039928
COMPOSITIONS AND METHODS FOR TREATING TARDBP ASSOCIATED DISEASES Nov 7, 2021 Pending
Array ( [id] => 18895539 [patent_doc_number] => 20240011024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => CRISPR SPACER TAGS FOR LABELING AND/OR IDENTIFYING BACTERIA, AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/251636 [patent_app_country] => US [patent_app_date] => 2021-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13716 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251636 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/251636
CRISPR SPACER TAGS FOR LABELING AND/OR IDENTIFYING BACTERIA, AND METHODS OF USING THE SAME Nov 3, 2021 Pending
Array ( [id] => 18842636 [patent_doc_number] => 20230405040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITH LPA-TARGETED RNAi CONSTRUCTS [patent_app_type] => utility [patent_app_number] => 18/035198 [patent_app_country] => US [patent_app_date] => 2021-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30408 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -144 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035198 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/035198
METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITH LPA-TARGETED RNAi CONSTRUCTS Nov 3, 2021 Pending
Array ( [id] => 18769366 [patent_doc_number] => 20230364127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6 [patent_app_type] => utility [patent_app_number] => 18/248036 [patent_app_country] => US [patent_app_date] => 2021-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66512 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -65 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248036 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/248036
EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6 Oct 5, 2021 Pending
Array ( [id] => 18282936 [patent_doc_number] => 20230098408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => SINGLE NUCLEIC ACID FOR REAL-TIME DETECTION FOR SNP ANALYSIS OF APOE GENE AND DETECTION METHOD USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/449140 [patent_app_country] => US [patent_app_date] => 2021-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7616 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 272 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17449140 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/449140
SINGLE NUCLEIC ACID FOR REAL-TIME DETECTION FOR SNP ANALYSIS OF APOE GENE AND DETECTION METHOD USING THE SAME Sep 27, 2021 Abandoned
Array ( [id] => 17444199 [patent_doc_number] => 20220064704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => METHODS OF PREPARING LARGE QUANTITIES OF SINGLE-STRANDED DNA (ssDNA) [patent_app_type] => utility [patent_app_number] => 17/410925 [patent_app_country] => US [patent_app_date] => 2021-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17232 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410925 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/410925
METHODS OF PREPARING LARGE QUANTITIES OF SINGLE-STRANDED DNA (ssDNA) Aug 23, 2021 Abandoned
Array ( [id] => 17370385 [patent_doc_number] => 20220025437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => NOVEL METHOD OF COMBINED MOLECULAR CLAMPING AND ALLELE SPECIFIC qPCR TECHNOLOGY FOR KRAS G12C MUTATION DETECTION [patent_app_type] => utility [patent_app_number] => 17/386451 [patent_app_country] => US [patent_app_date] => 2021-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8528 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17386451 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/386451
NOVEL METHOD OF COMBINED MOLECULAR CLAMPING AND ALLELE SPECIFIC qPCR TECHNOLOGY FOR KRAS G12C MUTATION DETECTION Jul 26, 2021 Abandoned
Array ( [id] => 18675551 [patent_doc_number] => 20230313159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => VARIANTS OF CAS NUCLEASE [patent_app_type] => utility [patent_app_number] => 18/005973 [patent_app_country] => US [patent_app_date] => 2021-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9707 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005973 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/005973
VARIANTS OF CAS NUCLEASE Jul 25, 2021 Abandoned
Array ( [id] => 18565730 [patent_doc_number] => 20230256057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => TREATMENT OF IMMUNE DEPRESSION [patent_app_type] => utility [patent_app_number] => 18/015820 [patent_app_country] => US [patent_app_date] => 2021-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37162 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015820 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/015820
TREATMENT OF IMMUNE DEPRESSION Jul 12, 2021 Abandoned
Array ( [id] => 18537810 [patent_doc_number] => 20230242911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => MicroRNA-TARGETED THERAPY FOR CARDIAC REPAIR [patent_app_type] => utility [patent_app_number] => 18/004877 [patent_app_country] => US [patent_app_date] => 2021-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10309 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004877 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/004877
MicroRNA-TARGETED THERAPY FOR CARDIAC REPAIR Jul 8, 2021 Abandoned
Array ( [id] => 19641419 [patent_doc_number] => 20240415939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-19 [patent_title] => COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/002767 [patent_app_country] => US [patent_app_date] => 2021-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23245 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002767 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/002767
COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF Jun 29, 2021 Pending
Array ( [id] => 18550778 [patent_doc_number] => 20230248778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => THERAPEUTIC USE OF OF CELL-FREE FAT EXTRACT FOR PULMONARY DISEASES [patent_app_type] => utility [patent_app_number] => 18/001259 [patent_app_country] => US [patent_app_date] => 2021-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8519 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001259 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/001259
THERAPEUTIC USE OF OF CELL-FREE FAT EXTRACT FOR PULMONARY DISEASES Jun 10, 2021 Pending
Array ( [id] => 18497713 [patent_doc_number] => 20230220391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => CILP-1 Inhibitors for Use in the Treatment of Dilated Cardiomyopathies [patent_app_type] => utility [patent_app_number] => 18/009018 [patent_app_country] => US [patent_app_date] => 2021-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14054 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009018 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/009018
CILP-1 Inhibitors for Use in the Treatment of Dilated Cardiomyopathies Jun 8, 2021 Pending
Array ( [id] => 18420557 [patent_doc_number] => 20230175019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => SCALABLE TRIO GUIDE RNA APPROACH FOR INTEGRATION OF LARGE DONOR DNA [patent_app_type] => utility [patent_app_number] => 17/927454 [patent_app_country] => US [patent_app_date] => 2021-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12849 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927454 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/927454
SCALABLE TRIO GUIDE RNA APPROACH FOR INTEGRATION OF LARGE DONOR DNA May 27, 2021 Pending
Array ( [id] => 18436456 [patent_doc_number] => 20230183750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => HDR ENHANCERS [patent_app_type] => utility [patent_app_number] => 17/999307 [patent_app_country] => US [patent_app_date] => 2021-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7287 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999307 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999307
HDR ENHANCERS May 19, 2021 Pending
Array ( [id] => 18417733 [patent_doc_number] => 20230172189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => Methods for Extending the Shelf-life of Stored Donor Blood and/or Red Blood Cells and Treated Red Blood Cell Compositions Produced Thereby [patent_app_type] => utility [patent_app_number] => 17/919364 [patent_app_country] => US [patent_app_date] => 2021-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6267 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919364 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/919364
Methods for Extending the Shelf-life of Stored Donor Blood and/or Red Blood Cells and Treated Red Blood Cell Compositions Produced Thereby Apr 25, 2021 Abandoned
Array ( [id] => 18510019 [patent_doc_number] => 20230226114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/916166 [patent_app_country] => US [patent_app_date] => 2021-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7976 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916166 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/916166
COMPOSITION Apr 1, 2021 Pending
Array ( [id] => 18333994 [patent_doc_number] => 20230125942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => METHOD FOR EDITING TARGET RNA [patent_app_type] => utility [patent_app_number] => 17/915232 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18108 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915232 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/915232
METHOD FOR EDITING TARGET RNA Mar 30, 2021 Pending
Array ( [id] => 18497665 [patent_doc_number] => 20230220331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => TEMPORARY TREATMENT MEDIUM, TREATMENT KIT, EMBRYOGENESIS ARREST INHIBITOR, EMBRYOGENESIS ARREST INHIBITORY METHOD, DEVELOPMENTAL ENGINEERING PRODUCT PREPARATION METHOD, TRANSPLANTATION METHOD, THERAPEUTIC METHOD, AND DEVELOPMENTAL ENGINEERING PRODUCT [patent_app_type] => utility [patent_app_number] => 17/914323 [patent_app_country] => US [patent_app_date] => 2021-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18931 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914323 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/914323
TEMPORARY TREATMENT MEDIUM, TREATMENT KIT, EMBRYOGENESIS ARREST INHIBITOR, EMBRYOGENESIS ARREST INHIBITORY METHOD, DEVELOPMENTAL ENGINEERING PRODUCT PREPARATION METHOD, TRANSPLANTATION METHOD, THERAPEUTIC METHOD, AND DEVELOPMENTAL ENGINEERING PRODUCT Mar 22, 2021 Pending
Menu